14-day Premium Trial Subscription Try For FreeTry Free

Latest Data & Signals Issued

Signal Type Signal Value Data
Score 0.000 67 days ( -3.20 % )
Last Price $5.81 0 %
High/ Low $5.81 - $5.81 0%
Chg 7 Days N/A $5.81 $5.81
Chg 30 Days N/A $5.81 $5.81
Chg 12 mos 26.30 % $4.60 $5.81
Trend - 3 mos -0.0300 % Width: 0.344 %
Trend - 12 mos 9.97 % Width: 66.39 %
Pred. range - 3 mos $5.81 - $5.83 -0.0608 % - 0.283 %
Pred. range - 12 mos $4.83 - $8.04 -16.79 % - 38.44 %
Short MA avg 3 mos Sell Mar 06, 2023 - 59 days
Long MA avg 3 mos Sell Apr 14, 2023 - 31 days
Short/Long MA avg 3 mos Sell Apr 14, 2023 - 31 days
Short MA avg 12 mos Sell Mar 13, 2023 - 54 days
Long MA avg 12 mos Sell Jan 25, 2023 - 86 days
Short/Long MA avg 12 mos Buy Jan 20, 2023 - 89 days
Pivot Short Sell Feb 28, 2023 - 63 days
Bollinger Sell Nov 30, -1 - N/A days
MACD N/A No Dates Stored For This Signal
Click to get the best stock tips daily for free!

About KemPharm

KemPharm KemPharm, Inc., a specialty pharmaceutical company, discovers and develops various proprietary prodrugs to treat serious medical conditions in the United States. The company utilizes its Ligand Activated Therapy technology to generate improved prodrug versions of FDA-approved drugs, as well as to generate prodrug versions of existing compounds that may have applications for new disease indications. Its prodrug product candidate pipeline is focuse... KMPH Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT